DK129652B - 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener. - Google Patents

17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.

Info

Publication number
DK129652B
DK129652B DK227069AA DK227069A DK129652B DK 129652 B DK129652 B DK 129652B DK 227069A A DK227069A A DK 227069AA DK 227069 A DK227069 A DK 227069A DK 129652 B DK129652 B DK 129652B
Authority
DK
Denmark
Prior art keywords
hydrocarbon
substituted
alkyl
gonenes
gon
Prior art date
Application number
DK227069AA
Other languages
English (en)
Other versions
DK129652C (da
Inventor
G Hughes
H Smith
Original Assignee
Smith Herchel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Herchel filed Critical Smith Herchel
Publication of DK129652B publication Critical patent/DK129652B/da
Application granted granted Critical
Publication of DK129652C publication Critical patent/DK129652C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A43FOOTWEAR
    • A43BCHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B3/00Footwear characterised by the shape or the use
    • A43B3/12Sandals; Strap guides thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Woven Fabrics (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
DK227069AA 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener. DK129652B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.

Publications (2)

Publication Number Publication Date
DK129652B true DK129652B (da) 1974-11-04
DK129652C DK129652C (da) 1975-04-07

Family

ID=10397775

Family Applications (6)

Application Number Title Priority Date Filing Date
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK227069AA DK129652B (da) 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Country Status (12)

Country Link
AT (4) AT264730B (da)
CH (5) CH450407A (da)
CY (1) CY429A (da)
DE (4) DE1468604C2 (da)
DK (6) DK113641B (da)
ES (1) ES281669A1 (da)
FI (4) FI41026B (da)
FR (1) FR2796M (da)
GB (2) GB1041279A (da)
MY (1) MY6800075A (da)
NO (4) NO122643B (da)
SE (6) SE312552B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636404C2 (de) * 1976-08-12 1983-12-08 Schering AG, 1000 Berlin und 4709 Bergkamen Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN104926906B (zh) * 2015-06-04 2016-02-10 保定北瑞甾体生物有限公司 一种17α-羟基黄体酮的制备方法

Also Published As

Publication number Publication date
AT256354B (de) 1967-08-25
DE1793608B1 (de) 1972-05-04
FR2796M (fr) 1964-09-21
NO122645B (da) 1971-07-26
SE312552B (da) 1969-07-21
DE1617818B2 (de) 1976-12-09
NO122643B (da) 1971-07-26
DE1468604B1 (de) 1970-07-02
SE313809B (da) 1969-08-25
CH455763A (de) 1968-05-15
SE312551B (da) 1969-07-21
AT256356B (de) 1967-08-25
DK113641B (da) 1969-04-14
AT264730B (de) 1968-09-10
GB1041279A (en) 1966-09-01
FI41024B (da) 1969-04-30
AT256355B (de) 1967-08-25
NO122646B (da) 1971-07-26
DK129652C (da) 1975-04-07
DK124753B (da) 1972-11-20
DE1793595B2 (de) 1975-10-30
CH459195A (de) 1968-07-15
DE1618855B2 (de) 1973-04-05
CH450408A (de) 1968-01-31
CH432509A (de) 1967-03-31
SE340619B (da) 1971-11-29
SE312553B (da) 1969-07-21
DK115621B (da) 1969-10-27
CH450407A (de) 1968-01-31
FI41025B (da) 1969-04-30
MY6800075A (en) 1968-12-31
DK115549B (da) 1969-10-20
DE1617818A1 (de) 1972-05-18
CY429A (en) 1968-01-15
DE1468604C2 (de) 1971-03-04
SE335526B (da) 1971-06-01
DE1618855C3 (da) 1973-10-25
DK121228B (da) 1971-09-27
FI41026B (da) 1969-04-30
ES281669A1 (es) 1963-03-16
FI41027B (da) 1969-04-30
NO122644B (da) 1971-07-26
GB1041278A (en) 1966-09-01
DE1793595A1 (de) 1972-02-03
DE1618855A1 (de) 1972-05-18

Similar Documents

Publication Publication Date Title
DK125133B (da) Aza-dibenzo-[a,d]-cyclohepten-derivater til anvendelse som mellemprodukter ved fremstilling af terapeutisk virksomme 5-substituerede aza-dibenzo-cycloheptener.
DK129652B (da) 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK122960B (da) Quinazolinderivater til anvendelse som mellemprodukter ved fremstillingen af 1,4-benzodiazepin-4-oxider.
DK104363C (da) Fremgangsmåde til fremstilling af symmetriske 4-halogen-4',4''-diarylamino-triphenylmethanfarvestoffer.
DK112306B (da) Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater.
DK128678B (da) Carbobenzoamid-kasugamycin-derivater til anvendelse som mellemprodukter ved fremstilligen af biologisk aktive kasugamycin-derivater, samt fremgangsmåde til fremstilling af carbobenzoamid-kasugamycin-derivaterne.
DK103396C (da) Fremgangsmåde til fremstilling af estere af 17α-ethynyl-5(10)-estren-3β,17β-diol.
DK128896B (da) 8-Hydroxy-13-alkylgona-1,3,5(10),9(11)-tetraener til anvendelse som mellemprodukter ved fremstillingen af 13-alkylgona-1,3,5(10),7-teraener.
DK116280B (da) Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider.
DK127592B (da) Substituerede phenylhexanoner til anvendelse som mellemprodukter ved fremstilling af gonanderivater.
FI52849C (fi) Terapetuttisesti vaikuttavien 5-fenyyli-3H-1,4-bentsodiatsepin-2(1H9-o nien valmistuksessa välituotteina käytetyt 2-karbobentsoksiglysyyliami do-bentsofenoni-johdannaiset.
DK135803B (da) 3,3,6-trimethyl-4-arylsulfonyl-5-hepten-1-syrederivater til anvendelse som mellemprodukter ved fremstilling af trans-chrysantheminsyrederivater.
DK96695C (da) Fremgangsmåde til fremstilling af 1α,11α-epoxy-3,5,14,19-tetrahydroxy-20(22)-cardenolid.
DK105155C (da) Fremgangsmåde til fremstilling af natruimslatet af 3,5-disulfaminobenzheparid.
DK94561C (da) Fremgangsmåde til fremstilling af 3-acyloxy-2,4,6-pregnatrienforbindelser.
DK98001C (da) Fremgangsmåde til fremstilling af 3-oxo-14-hydroxy-11α,19-diacetoxy-(1,4)-cardadienolid.
DK113014B (da) Fremgangsmåde til fremstilling af methyl-2,5-hexadienoat.
DK99567C (da) Fremgangsmåde til fremstilling af 4-oxa-tetracyclo-(6:2:1:0<2,7>:0<3,5>)-hendecanderivater.
DK103671C (da) Fremgangsmåde til fremstilling af 2,2'4,4'-tetrabrom-N-alkyl-diphenylaminer.
DK97513C (da) Fremgangsmåde til fremstilling af 3,11-dioxo-17α-hydroxy-20β,21-dinitrato-Δ<4>-pregnen.
DK102857C (da) Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<4,6>-pregnadiener.
DK101297C (da) Fremgangsmåde til fremstilling af 3-keto-6α-trifluormethyl-Δ<1,4>-pregnadiener.
DK101056C (da) Fremgangsmåde til fremstilling af 3-keto-6-trifluormethyl-Δ<1,4,6>-pregnatriener.
DK98239C (da) Fremgangsmåde til fremstilling af 2-alkoxy-3,17-diketo-11β-hydroxy-Δ<1,4>-androstadiener.
DK100423C (da) Fremgangsmåde til fremstilling af 3-oxo-11β-hydroxy-17β-hydroxy- eller -acyloxy-Δ<4>-estren-10β-carboxylsyre-11,19-lactoner.